tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market
BRNS
Barinthus Biotherapeutics
RESEARCH TOOLSreports
Want to see BRNS full AI Analyst Report?

Barinthus Biotherapeutics (BRNS) Income Statement

108 Followers

Barinthus Biotherapeutics Income Statement

Last quarter (Q1 2026), Barinthus Biotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Barinthus Biotherapeutics's net income was $-5.53M. See Barinthus Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 14.97M$ 802.00K$ 44.70M$ 268.00K
Gross Profit
$ -5.86M$ 14.97M$ 802.00K$ 44.70M$ 268.00K
Operating Expenses
$ 48.34M$ 82.94M$ 84.72M$ 48.74M$ 45.49M
Depreciation and Amortization
$ 5.84M$ 5.80M$ 5.43M$ 4.32M$ 602.00K
EBITDA
$ -48.34M$ -55.37M$ -71.06M$ 5.19M$ -47.87M
Operating Income
$ -54.19M$ -67.97M$ -83.91M$ -4.04M$ -45.22M
Other Income/Expenses
$ -14.60M$ 6.74M$ 7.39M$ 4.89M$ -5.92M
Pretax Income
$ -68.79M$ -61.23M$ -76.52M$ 850.00K$ -51.14M
Net Income
$ -66.43M$ -61.07M$ -73.35M$ 5.34M$ -50.87M
Per Share Metrics
Basic EPS
$ -1.64$ -1.55$ -1.91$ 0.14$ -1.37
Diluted EPS
$ -1.64$ -1.55$ -1.91$ 0.14$ -1.37
Weighted Average Shares Outstanding
 40.53M 39.35M 38.39M 37.25M 37.19M
Weighted Average Shares Outstanding (Diluted)
 40.53M 39.35M 38.39M 38.17M 37.19M
Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History